OPENING THE 'BLACK BOX' ON TEZEPELUMAB'S EFFECT OF CHRONIC RHINOSINUSITIS WITH SEVERE ASTHMA

Registry ID

ESR-24-22412

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

ST PAUL'S SINUS CENTRE

Start date

2026-08-15

Last update

2024-10-29

Conditions

• RHINOSINUSITIS

Related clinical trials

• A DOUBLE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) WHO PARTICIPATED IN EITHER EFC18418 OR EFC18419 CLINICAL STUDIES
• THE EFFICACY OF INTRA-SINUS POVIDONE-IODINE/BUDESONIDE GEL FORMING SUSPENSION FOLLOWING ENDOSCOPIC SINUS SURGERY FOR CHRONIC RHINOSINUSITIS: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT (POC) STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS
• A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB/LY3650150 IN ADULT PARTICIPANTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS ON BACKGROUND INTRANASAL CORTICOSTEROIDS

View on source registry